 |
市場調查報告書
商品編碼
2058290
癒創甘油醚（原料藥）市場：按劑型、應用、最終用戶和地區分類Guaifenesin (API) Market, By Formulation Type, By Application, By End User, By Geography |
||||||
預計到 2026 年，癒創甘油醚（原料藥）市場規模為 9,470 萬美元，到 2033 年將達到 1.286 億美元。預計從 2026 年到 2033 年，其複合年成長率將達到 4.5%。
| 報告範圍 | 報告詳情 | ||
|---|---|---|---|
| 基準年： | 2025 | 2026年市場規模： | 9470萬美元 |
| 歷史數據時期： | 2020年至2024年 | 預測期： | 2026年至2033年 |
| 2026年至2033年預測期間的複合年成長率： | 4.50% | 2033年市場規模預測： | 1.286億美元 |
癒創甘油醚原料藥是全球製藥業廣泛使用的活性藥物成分。它作為多種祛痰藥的活性成分，用於治療呼吸系統疾病。作為一種黏液溶解劑，癒創甘油醚原料藥有助於快速清除呼吸系統中的黏液。過去幾年，全球癒創甘油醚（原料藥）市場經歷了強勁成長。這一成長歸功於人們對呼吸系統疾病及相關健康問題的日益關注，以及新興國家製藥生產基礎設施的快速發展。
全球癒創甘油醚（原料藥）市場包括藥用級、食品級和工業級癒創甘油醚原料藥。由於藥用級癒創甘油醚原料藥受到嚴格的監管和品質標準約束，因此其市佔率最大。全球癒創甘油醚原料藥市場受季節性需求模式、監管合規成本、原料價格以及原料藥生產技術進步的顯著影響。全球癒創甘油醚原料藥市場的主要參與者包括大型醫藥原料生產商、契約製造組織（CMO）和原料藥生產商。這些企業的競爭優勢體現在產品品質、監管合規性、成本和供應可靠性等。癒創甘油醚原料藥作為一種藥物活性成分，在緩解全球呼吸系統疾病的影響方面發揮著至關重要的作用。
市場動態
全球癒創甘油醚（原料藥）市場呈現穩健成長態勢，這主要得益於許多有利的市場促進因素。這些因素包括：全球呼吸系統疾病發生率上升導致對含癒創甘油醚原料藥的祛痰藥需求持續成長；人口老化加劇，老年人健康狀況下降，更容易患上需要藥物幹預的呼吸系統疾病；以及公眾健康意識的提高，促使人們更多地使用自我治療和成藥。
然而，許多重大限制仍然存在，包括來自美國FDA和EMA等監管機構的監管挑戰、原料價格波動、發展中國家學名藥生產商之間激烈的價格競爭以及專利到期。這些因素造成價格壓力，限制了市場成長機會。儘管如此，仍存在相當大的機遇，例如開發中國家擴大生產能力以實現低成本生產、推出包含癒創甘油醚原料藥在內的新製劑，以及監管市場對高品質原料藥的需求不斷成長。
本次調查的主要特點
- 本研究確定了各個細分市場的潛在商機，並說明了該市場具有吸引力的投資提案矩陣。
- 此外，本研究還深入分析了市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域展望以及主要參與者採取的競爭策略。
- 本研究根據以下參數介紹了全球癒創甘油醚（API）市場主要公司的概況：公司亮點、產品系列、關鍵亮點、財務表現和策略。
- 透過利用本報告中的見解，企業負責人和經營團隊將能夠就未來的產品發布、產品類型升級、市場擴張和行銷策略做出明智的決策。
- 這份全球癒創甘油醚（API）市場報告針對產業內的各種相關人員，包括投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師。
- 透過分析全球癒創甘油醚（API）市場的各種策略矩陣，相關人員將能夠更輕鬆地做出決策。
目錄
第1章：研究目標與前提條件
- 分析目的
- 先決條件
- 簡稱
第2章 市場展望
- 報告說明
- 市場定義和範圍
- 執行摘要
第3章：市場動態、監管與趨勢分析
- 市場動態
- 影響分析
- 主要亮點
- 監管趨勢
- 產品上市及核准
- PEST分析
- 波特的分析
- 市場機遇
- 監管趨勢
- 主要進展
- 產業趨勢
第4章 全球癒創甘油醚（原料藥）市場：依製劑類型分類，2021-2033年
- 標準版
- 緩釋製劑
第5章 全球癒創甘油醚（原料藥）市場：依應用領域分類，2021-2033年
- 止咳糖漿和祛痰藥
- 片劑和膠囊
- 呼吸系統複合藥物
- 其他
第6章 全球癒創甘油醚（原料藥）市場：依最終用戶分類，2021-2033年
- 製藥公司
- 非處方藥保健品製造商
- 契約製造公司（CMO）
- 其他
第7章 全球癒創甘油醚（原料藥）市場：依地區分類，2021-2033年
- 北美洲
- 美國
- 加拿大
- 拉丁美洲
- 巴西
- 阿根廷
- 墨西哥
- 其他拉丁美洲國家
- 歐洲
- 德國
- 英國
- 西班牙
- 法國
- 義大利
- 俄羅斯
- 其他歐洲國家
- 亞太地區
- 中國
- 印度
- 日本
- 澳洲
- 韓國
- ASEAN
- 其他亞太國家
- 中東
- 海灣合作理事會國家
- 以色列
- 其他中東國家
- 非洲
- 南非
- 北非
- 中非
第8章 競爭情勢
- Granules India Limited
- Synthokem Labs Pvt. Ltd.
- LGM Pharma
- Sanofi
- Transo-Pharm USA LLC
- Chunghwa Chemical Synthesis & Biotech Co., Ltd.
- Tenatra Exports
- Gennex Laboratories Limited
- Haizhou Pharma
- Delta Synthetic Co.
第9章 分析師建議
- 機會分析
- 分析師意見
- Coherent Opportunity Map
第10章 參考文獻與調查方法
- 參考
- 調查方法
- 關於本公司
Guaifenesin (API) Market is estimated to be valued at USD 94.7 Mn in 2026 and is expected to reach USD 128.6 Mn by 2033, growing at a compound annual growth rate (CAGR) of 4.5% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 94.7 Mn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 4.50% | 2033 Value Projection: | USD 128.6 Mn |
Guaifenesin API is an active pharmaceutical ingredient that finds wide applications in the pharmaceutical manufacturing industry around the world. It acts as the active therapeutic ingredient in various expectorant medications formulated to combat respiratory problems. As a mucolytic agent, the Guaifenesin API helps in the fast removal of mucous from the respiratory system. The global guaifenesin (API) market has experienced strong growth over the past few years. This growth can be attributed to the increasing awareness of respiratory issues and related health problems as well as the rapid expansion of pharmaceutical manufacturing infrastructure in emerging economies.
The global guaifenesin (API) market comprises of the pharmaceutical, food and industrial grades of Guaifenesin API. The pharmaceutical grade market accounts for the largest share in the global guaifenesin (API) market owing to the high stringent regulations and quality standards imposed in this regard. The global guaifenesin (API) market is significantly impacted by the seasonal demand pattern, regulatory compliance costs, prices of raw materials and breakthroughs in API manufacturing technology. Leading players in the global guaifenesin (API) market are major pharmaceutical ingredients manufacturers, contract manufacturing organizations and API manufacturers. The competitive positioning of these players is based on the quality, adherence to regulations, costs and dependability of supply of the product. Guaifenesin API as a pharmaceutical active ingredient plays an important role in mitigating the effects of respiratory health issues around the world.
Market Dynamics
The global guaifenesin (API) market is characterized by healthy growth momentum supported by a number of attractive market drivers, such as the rising incidence of respiratory diseases around the globe leading to a sustained demand for expectorants containing guaifenesin API; the aging population, which due to deteriorating health conditions, is more likely to suffer from respiratory diseases requiring pharmaceutical interventions; the increasing awareness among masses, which boosts self-medication and OTC consumption; and others.
However, a number of important restraining factors such as regulatory challenges posed by regulatory authorities including U.S. FDA, EMA and others, raw material price fluctuation, intense price wars among generic manufacturing players in developing markets, patent expiry of the API, and others, create pricing pressure and limit growth opportunities of the market. Nevertheless, considerable opportunities exist in the form of expanding manufacturing capacities in developing countries for low-cost manufacturing, introduction of novel combination formulations including guaifenesin API, increasing demand for high quality APIs in regulated markets, and others.
Key Features of the Study
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global guaifenesin (API) market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include Granules India Limited, Synthokem Labs Pvt. Ltd., LGM Pharma, Sanofi, Transo-Pharm USA LLC, Chunghwa Chemical Synthesis & Biotech Co., Ltd., Tenatra Exports, Gennex Laboratories Limited, Haizhou Pharma, and Delta Synthetic Co.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global guaifenesin (API) market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global guaifenesin (API) market
Market Segmentation
- Formulation Type Insights (Revenue, USD Mn, 2021 - 2033)
- Standard Release
- Extended Release
- Application Insights (Revenue, USD Mn, 2021 - 2033)
- Cough Syrups and Expectorants
- Tablets and Capsules
- Combination Respiratory Drugs
- Others
- End User Insights (Revenue, USD Mn, 2021 - 2033)
- Pharmaceutical Manufacturers
- OTC Healthcare Manufacturers
- Contract Manufacturing Organizations (CMOs)
- Others
- Regional Insights (Revenue, USD Mn, 2021 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- Granules India Limited
- Synthokem Labs Pvt. Ltd.
- LGM Pharma
- Sanofi
- Transo-Pharm USA LLC
- Chunghwa Chemical Synthesis & Biotech Co., Ltd.
- Tenatra Exports
- Gennex Laboratories Limited
- Haizhou Pharma
- Delta Synthetic Co.
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Global Guaifenesin (API) Market, By Formulation Type
- Global Guaifenesin (API) Market, By Application
- Global Guaifenesin (API) Market, By End User
- Global Guaifenesin (API) Market, By Region
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Impact Analysis
- Key Highlights
- Regulatory Scenario
- Product Launches/Approvals
- PEST Analysis
- PORTER's Analysis
- Market Opportunities
- Regulatory Scenario
- Key Developments
- Industry Trends
4. Global Guaifenesin (API) Market, By Formulation Type, 2021-2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Standard Release
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Extended Release
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
5. Global Guaifenesin (API) Market, By Application, 2021-2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Cough Syrups and Expectorants
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Tablets and Capsules
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Combination Respiratory Drugs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
6. Global Guaifenesin (API) Market, By End User, 2021-2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Pharmaceutical Manufacturers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- OTC Healthcare Manufacturers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Contract Manufacturing Organizations (CMOs)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
7. Global Guaifenesin (API) Market, By Region, 2021 - 2033, Value (USD Mn)
- Introduction
- Market Share (%) Analysis, 2026, 2029 & 2033, Value (USD Mn)
- Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Mn)
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, By Formulation Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, By Formulation Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, By Formulation Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, By Formulation Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, By Formulation Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, By Formulation Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Mn)
- South Africa
- North Africa
- Central Africa
8. Competitive Landscape
- Granules India Limited
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Synthokem Labs Pvt. Ltd.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- LGM Pharma
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Sanofi
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Transo-Pharm USA LLC
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Chunghwa Chemical Synthesis & Biotech Co., Ltd.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Tenatra Exports
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Gennex Laboratories Limited
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Haizhou Pharma
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Delta Synthetic Co.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
9. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
10. References and Research Methodology
- References
- Research Methodology
- About us
